Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
ACETAZOLAMIDA ARENA 250 mg
Carbonic anhydrase inhibitor diuretic, indicated in the treatment of glaucoma and epilepsy
Active Substance (INN)
ACETAZOLAMIDUM
Packaging
2 blisters x 10 tablets
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction FormRead the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.